XML 80 R65.htm IDEA: XBRL DOCUMENT v3.22.1
Equity - Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Number of Shares    
Beginning balance (in shares) 36,576  
Options granted (in shares) 1,966  
Options exercised (in shares) (10,823)  
Options forfeited and expired (in shares) (736)  
Ending balance (in shares) 26,983 36,576
Vested and exercisable, at end of period (in shares) 8,113  
Vested and expected to vest, at end of period (in shares) 25,021  
Weighted-Average Exercise Price    
Beginning balance (in dollars per share) $ 2.80  
Granted (in dollars per share) 12.56  
Exercised (in dollars per share) 1.17  
Forfeited or expired (in dollars per share) 3.16  
Ending balance (in dollars per share) 4.15 $ 2.80
Weighted average exercise price, vested and exercisable at period end (in dollars per share) 1.77  
Weighted average exercise price, vested and expected to vest at period end (in dollars per share) $ 4.02  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Average remaining contractual term, outstanding 7 years 7 months 17 days 7 years 10 months 9 days
Average remaining contractual term, vested and exercisable at period end 6 years 1 month 24 days  
Average remaining contractual term, vested and expected to vest at period end 7 years 6 months 18 days  
Aggregate intrinsic value, outstanding $ 1,293,545 $ 357,366
Aggregate intrinsic value, vested and exercisable at period end 408,238  
Aggregate intrinsic value, vested and expected to vest at period end $ 1,202,634